The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors
Open accessAbstract
The dense collagen network in tumors significantly reduces the penetration and efficacy of nanotherapeutics. We tested whether losartan—a clinically approved angiotensin II receptor antagonist with noted antifibrotic activity—can enhance the penetration and efficacy of nanomedicine. We found that losartan inhibited collagen I production by carcinoma-associated fibroblasts isolated from breast cancer biopsies. Additionally, it led to a dose-dependent reduction in stromal collagen in desmoplastic models of human breast, pancreatic, and skin tumors in mice. Furthermore, losartan improved the distribution and therapeutic efficacy of intratumorally injected oncolytic herpes simplex viruses. Finally, it also enhanced the efficacy of i.v. injected pegylated liposomal doxorubicin (Doxil). Thus, losartan has the potential to enhance the efficacy of nanotherapeutics in patients with desmoplastic tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Increased mechanical stress can collapse blood vessels, leading to hypoxia, thereby promoting more aggressive cancer phenotypes, and reducing drug delivery89,100–105.”
From A framework for advancing our understanding of cancer-associated fibroblasts (2020) · cites this paper as [100]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Delivering nanomedicine to solid tumors
Jain, R. K., & Stylianopoulos, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.139 · Cited by 3,265
Self-citationOlive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Collagens—structure, function, and biosynthesis
Gelse, K. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.08.002 · Cited by 2,777
Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan Syndrome
Habashi, J. P., Judge, D. P., Holm, T. M., Cohn, R. D., Loeys, B. L., Cooper, T. K., Myers, L., Klein, E. C., Liu, G., Calvi, C., et al. (2006) · Science · doi:10.1126/science.1124287 · Cited by 1,794
Molecular mechanisms of drug resistance
Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726
Role of extracellular matrix assembly in interstitial transport in solid tumors.
Netti, P. A., Berk, D. A., Swartz, M. A., Grodzinsky, A. J., & Jain, R. K. (2000) · PubMed · Cited by 1,165
Self-citationDynamic imaging of collagen and its modulation in tumors in vivo using second-harmonic generation
Brown, E. B., McKee, T. D., DiTomaso, E., Pluen, A., Seed, B., Boucher, Y., & Jain, R. K. (2003) · Nature Medicine · doi:10.1038/nm879 · Cited by 844
Self-citation
Cited by
Sorted by citations
Items 601–700 of 734
Guerrero, M., Hernández, J., Gómez, L. A., & Guerrero, C. (2023) · Virus Research · doi:10.1016/j.virusres.2023.199285 · Cited by 4
Zhang, H., Wang, Q., Li, J., Zhou, J., & Chen, Q. (2025) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2025.115314 · Cited by 4
Normalizing the Tumor Microenvironment: A New Frontier in Ovarian Cancer Therapy
Jones, A. P., Zhao, Y., Rueda, B. V., Yeku, O., & Xu, L. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27020939 · Cited by 4
Shrestha, S., Adib, E., Imani, J., Aguiar, D. J., Lamattina, A. M., Tassew, D., Henske, E. P., Perrella, M. A., Priolo, C., & El‐Chemaly, S. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.102580 · Cited by 4
Bifurcation and Stability of a Mathematical Model for Tumor Growth with Oncolytic Virotherapy
Hong-bing, C. (2023) · International Journal of Bifurcation and Chaos · doi:10.1142/s0218127423501687 · Cited by 4
Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway
Wang, H., Liu, J., Fang, F., Gao, L., Zhao, C., Wang, Z., Zhong, Y. W., & Wang, X. (2024) · Nefrología (English Edition) · doi:10.1016/j.nefroe.2024.04.001 · Cited by 4
Sankhe, C. S., Sacco, J. L., Lawton, J., Fair, R. A., Soares, D. V. R., Aldahdooh, M. K. R., Gomez, E. D., & Gomez, E. W. (2024) · Advanced Biology · doi:10.1002/adbi.202400087 · Cited by 4
Next generation nanocomposite biomaterials for ligament repair and regeneration
Pashaki, P. V., Ravi, P., Jaswandkar, S. V., Noonan, B. C., Katti, D. R., & Katti, K. S. (2024) · Nanocomposites · doi:10.1080/20550324.2024.2399979 · Cited by 4
Lin, Y., Liao, Y., & Shen, J. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2464208 · Cited by 4
Liu, H., Sun, X., Dong, B., Zhang, J., Zhang, J., Gu, Y., Chen, L., Pang, X., Ye, J., Wang, X., et al. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70536 · Cited by 4
Gharehbaba, A. M., Soltanmohammadi, F., Eskandani, M., & Adibkia, K. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125979 · Cited by 4
The Effect of Stromal Integrin β3-Deficiency on Two Different Tumors in Mice
Reigstad, I., Sortland, K., Skogstrand, T., Reed, R. K., & Stuhr, L. E. B. (2016) · Cancers · doi:10.3390/cancers8010014 · Cited by 4
Barsoumian, H. B., Sheth, R. A., Ramapriyan, R., Hsu, E. Y., Gagea, M., Crowley, K., Sezen, D., Williams, M. L., & Welsh, J. W. (2022) · Advances in Radiation Oncology · doi:10.1016/j.adro.2022.101137 · Cited by 5
Modulating the tumor microenvironment improves antitumor effect of anti-PD-L1 mAb in breast cancer
Li, X., Luo, X., & Hu, S. (2023) · Bioimpacts · doi:10.34172/bi.2023.24166 · Cited by 4
Physiological Determinants and Plausible ‘6R’ Roadmap for Clinical Success of Nanomedicines
Shahiwala, A. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0114 · Cited by 4
Losartan ameliorates renal fibrosis by inhibiting tumor necrosis factor signal pathway
Wang, H., Liu, J., Fang, F., Gao, L., Zhao, C., Wang, Z., Zhong, Y. W., & Wang, X. (2023) · Nefrología · doi:10.1016/j.nefro.2023.09.001 · Cited by 4
Firing up the Tumor Microenvironment with Nanoparticle-Based Therapies
Pan, Y., Song, X., Wang, Y., & Wei, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091338 · Cited by 4
Wang, R., Qin, G.-H., Jiang, Y., Chen, F., Wang, Z., Ju, L., Chen, L., Fu, D., Liu, E., Zhang, S., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1592416 · Cited by 3
Ma, S., Wang, Q., Zhang, Y., Zhu, X., Chen, G. D., Liang, X., Liu, J., Wang, D., & Liu, L. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114900 · Cited by 4
Sulfonamide-Functionalized Polymeric Nanoparticles for Enhanced In Vivo Colorectal Cancer Therapy
Sinisterra, R. D., Guimarães, P. P. G., Viana, C. T. R., Pereira, L. D. A., Gontijo, S. M. D. L., Campos, P. P., Andrade, S. P., & Santos, R. A. S. (2021) · Current Drug Delivery · doi:10.2174/1567201818666210729110127 · Cited by 3
The application of nanomaterials in tumor therapy based on the regulation of mechanical properties
Wang, X., Yu, H., Liu, D., Hu, B., Zhang, R., Hu, L., Hu, G., & Li, C. (2024) · Nanoscale · doi:10.1039/d4nr01812e · Cited by 3
Stories of drug repurposing for pancreatic cancer treatment—Past, present, and future
Ilmer, M., Weniger, M., Nieß, H., Wu, Y. F., Zhang, C., Westphalen, C. B., Krüger, S., Angele, M. K., Werner, J. M., D’Haese, J. G., et al. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819668-7.00009-9 · Cited by 3
Oncolytic Viruses as Immunotherapeutic Agents
Trehub, Y., & Havrilov, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-50287-4_27 · Cited by 3
Non-invasive assessment for intratumoural distribution of interstitial fluid flow
Zhao, J., Cao, Y., Liu, W., & Han, D. C. (2023) · Magnetic Resonance Letters · doi:10.1016/j.mrl.2023.03.001 · Cited by 3
Repurposing Tamoxifen for Tumor Microenvironment Priming and Enhanced Tumor‐Targeted Drug Delivery
Biancacci, I., Santis, D. D., Rama, E., Benderski, K., Momoh, J., Pohlberger, R. F., Moeckel, D., Kaps, L., Rijcken, C. J. F., Prakash, J., et al. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300098 · Cited by 3
Viral Vectors for Treatment of Human Disease: Therapeutic and Manufacturing Challenges
Diallo, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814470-1.00007-1 · Cited by 3
Modes of Neovascularization in Tumors and Clinical Translation of Antiangiogenic Therapy
Jain, R. K., Fukumura, D., & Duda, D. G. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.05502-7 · Cited by 3
Self-citationDesigning an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition
Adiseshaiah, P. P., & Stern, S. T. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7352-1_20 · Cited by 3
Siregar, S., Rulianov, R., Ksatriapraja, R. A., & Stefanus, D. (2022) · F1000Research · doi:10.12688/f1000research.123040.1 · Cited by 3
Netrin G1 Ligand is a new stromal immunomodulator that promotes pancreatic cancerPreprint
Costa, D. B. V., Francescone, R., Franco‐Barraza, J., Luong, T., Graves, M., de Aquino, A. M., Steele, N. G., Gardiner, J. C., dos Santos, S. A. A., Ogier, C., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.15.594354 · Cited by 3
Arida, D. A., Osman, A., El-Deen, A. E.-S. N., Elzeiny, D. A., Elyamany, M. I., & Youssef, O. M. (2025) · Journal of Hazardous Materials Advances · doi:10.1016/j.hazadv.2025.100692 · Cited by 2
Wang, Z., Wang, H., Hou, R., Jiang, H., Fan, H., Zhang, Y., Zhu, Y., Cai, Y., Mei, J., & Xu, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1668782 · Cited by 2
Kpeglo, D., Haddrick, M., Knowles, M. A., Evans, S. D., & Peyman, S. A. (2025) · Scientific Reports · doi:10.1038/s41598-025-30612-2 · Cited by 2
Kontomaris, S. V., Psychogios, I., Malamou, A., Stylianopoulos, T., & Stylianou, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100365 · Cited by 2
Losartan primes pancreatic tumors for effective exosome-biomimetic chemo-immunotherapy
Hu, X., Wang, Z., Zhu, Y., Ma, P., Zheng, R., Zhi, X., Yan, H., Xiao, T., Tian, J., & Wang, Q. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.114745 · Cited by 2
Bhatt, P., Sahu, P., Mohapatra, P., Singh, M. S., & Roy, A. (2026) · Biomaterials Advances · doi:10.1016/j.bioadv.2026.214828 · Cited by 2
Targeting Tumor Stroma: Current Challenges and Future Directions
Wang, S., Hu, H., Zeng, W., Qin, L., Chen, X., Liao, Z., Liu, F., & Zhang, Z. (2026) · MedComm · doi:10.1002/mco2.70763 · Cited by 2
Tassano, M. R., Camacho, X., Freire, T., Perroni, C., da Costa, V., Cabrera, M., García, M. F., Fernández, M., Gambini, J. P., Cabral, P., et al. (2024) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2023.0138 · Cited by 2
Siregar, S., Rulianov, R., Ksatriapraja, R. A., & Stefanus, D. (2024) · F1000Research · doi:10.12688/f1000research.123040.3 · Cited by 2
Maruyama, M., Matsui, H., Nakamura, H., Torii, R., Takasugi, Y., Ogawara, K., & Higaki, K. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105647 · Cited by 2
Yang, H. Y., Kang, M. Y., Kang, C. M., Lee, W. J., & Hwang, H. K. (2024) · Yonsei Medical Journal · doi:10.3349/ymj.2023.0399 · Cited by 2
Renin-angiotensin-system and clear cell renal carcinoma: research advances and future perspectives
Yang, G., Wang, Y., Lai, Z.-W., Zhang, H., Zhang, Y., & Song, F. (2024) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2024.40 · Cited by 3
The roles of collagens in cancer
Willumsen, N., Nissen, N. I., & Karsdal, M. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817068-7.00034-3 · Cited by 2
Improving Oncolytic Herpes Simplex Virus for Metastatic Breast Cancer
Cody, J. J. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000126 · Cited by 2
A time for multi-scale modeling of anti-fibrotic therapies
Wu, M. (2016) · Physics of Life Reviews · doi:10.1016/j.plrev.2016.05.008 · Cited by 2
Biological barriers to cancer drug delivery, efficacy and cancer models
Madkour, L. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-819777-6.00018-4 · Cited by 2
Vascular Normalization in Cerebral Angiogenesis: Friend or Foe?
Lee, J., Baird, A., & Eliceiri, B. P. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0320-7_3 · Cited by 2
Siregar, S., Rulianov, R., Ksatriapraja, R. A., & Stefanus, D. (2023) · F1000Research · doi:10.12688/f1000research.123040.2 · Cited by 2
Mehta, A., Hwang, W. L., & Weekes, C. D. (2020) · Annals of Pancreatic Cancer · doi:10.21037/apc-2020-pda-05 · Cited by 2
Polymer-Based Tumor-targeted Nanosystems
Benli‐Hoppe, T., & Wagner, E. (2020) · Springer eBooks · doi:10.1007/978-981-15-5159-8_11 · Cited by 2
Comba, A., Faisal, S. M., Dunn, P. J., Argento, A. E., Hollon, T. C., Al‐Holou, W. N., Varela, M. L., Zamler, D. B., Quass, G. L., Apostolides, P. F., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.01.404970 · Cited by 2
Virus oncolíticos: un arma contra el cáncer
Fonseca, C. A. G., López-Baquero, M. A., & Bedoya-Rodríguez, A. A. (2019) · Revista de la Facultad de Medicina · doi:10.15446/revfacmed.v67n2.68347 · Cited by 1
Ghafar, M. T. A., & Helmy, A. A. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2023.12.002 · Cited by 1
The roles of collagens and fibroblasts in cancer
Nissen, N. I., Karsdal, M. A., Cox, T. R., & Willumsen, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15617-5.00029-9 · Cited by 2
Tumor-on-chip platforms for transport phenotyping: decoding CAF-driven barriers to drug delivery
Manach, D. L., Senez, V., & Nees, M. (2026) · Lab on a Chip · doi:10.1039/d5lc01131k · Cited by 1
Wang, Y., MaoYan, T., Peng, C., Yang, J., Liu, F., Ding, D., Guo, Y., Yu, Y., & Han, F. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116821 · Cited by 2
Li, W., Xin, Y.-Y., Jin, M.-Z., & Jin, W.-L. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103317 · Cited by 1
Tissue mechanopathology of cancer
Ivaska, J., Sale, S., & Yap, A. S. (2026) · Developmental Cell · doi:10.1016/j.devcel.2026.06.006 · Cited by 2
Hoang, T. A., Lee, E., Hwang, D., Cho, H. J., & Park, S. (2026) · Journal of Controlled Release · doi:10.1016/j.jconrel.2026.115345 · Cited by 1
Dey, G., Montēt, D., & Thonart, P. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818588-9.00015-2 · Cited by 1
Exploring the potential role of palladin in modulating human CAF / ECM functional units
Dolskiy, A. A., dos Santos, S. A. A., Andrake, M., Franco‐Barraza, J., Dunbrack, R. L., & Cukierman, E. (2024) · Cytoskeleton · doi:10.1002/cm.21926 · Cited by 1
Liu, K., Bie, J., Zhang, R., Xiong, R., Peng, L., Luo, Y., Yang, S., Feng, G., & Song, G. (2025) · International Journal of Oncology · doi:10.3892/ijo.2025.5738 · Cited by 2
Emerging Technologies for the Diagnosis and Treatment of Pancreatic Cancer
Swierczewska, M., Козлов, С. В., & Adiseshaiah, P. P. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811785-9.00022-3 · Cited by 1
Ang, J. (2016) · eScholarship (California Digital Library) · Cited by 1
Sun, Y., Yin, Z., Wu, L., Yue, C., Zhang, Y., Subudhi, S., Lei, P., Muzikansky, A., Zhang, L., Rueda, B. R., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555783 · Cited by 1
Self-citationSaini, K., Cho, S., Tewari, M., Jalil, A. R., Wang, M., Kasznel, A. J., Yamamoto, K., Chenoweth, D. M., & Discher, D. E. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.27.559759 · Cited by 1
Letter to the editor regarding recent article by Wu et al. [J. Theor. Biol. 355 (2014) pp. 194–207]
Jain, R. K., & Netti, P. A. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.08.052
Self-citationTargeting the Tumor Stroma in Breast Cancer
Sánchez-Ruíz, J., & Quintela-Fandiño, M. (2015) · Current Breast Cancer Reports · doi:10.1007/s12609-014-0173-9
Brinckerhoff, C. (2016) · Melanoma Management · doi:10.2217/mmt.15.36
Leonard, F., & Godin, B. (2016) · Fundamental biomedical technologies · doi:10.1007/978-3-319-43525-1_4
Development of CXCR4-Inhibiting Nanoparticles for the Treatment of Metastatic Cancer
Wang, Y. (2016) · DigitalCommons@UNMC
Mikhail, A. S. (2013) · TSpace (University of Toronto)
Korth, M. (2017) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-4364
Vincent, P., Gunn, J. R., Marra, K. A., Samkoe, K. S., Hoopes, P. J., Hasan, T. G., & Pogue, B. W. (2019) · Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy · doi:10.1117/12.2508796
Role of stromal SPARC in PDAC tumorigenesis and drug delivery
Ramu, I. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7723
Cai, X., Wang, Z., Xu, Y., Ye, L., Cao, J., Ni, J.-J., & Wu, T.-T. (2019) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-979020190002181035
Tumoral delivery of nanotherapeutics
Prabhu, P. S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821013-0.00024-6
Efficacy of losartan and growth hormone combinatorial therapy in DyW mice
Rhee, Younghwa, & Kandarian, S. C. (2014)
Martins, E. B. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2021.tde-23082021-101842
Stromal modulation strategies to improve immunotherapy response in cancer
Shi, K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-90949-5.00008-5
[A case of Marie-Leri syndrome].
Otto, L. (1966) · PubMed
Timpson, P. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737260944.793580089
The Effects of Angiotensin-Converting Enzyme Inhibitors on Metastasis-Associated Myeloid Cells
Vallejo-Ardila, D. L., Parra-Medina, R. S., Cómbita, A. L., Cardona, A. F., & Paquet‐Fifield, S. (2022) · Interdisciplinary cancer research · doi:10.1007/16833_2022_91
Martin, J. D., Lanning, R. M., Chauhan, V. P., Martin, M. R., Mousa, S. M., Kamoun, W. S., Han, H., Lee, H., Stylianopoulos, T., Bawendi, M. G., et al. (2023) · doi:10.1158/1078-0432.c.6532584.v1
Self-citationIncio, J., Liu, H., Suboj, P., Chin, S. M., Chen, I. X., Pinter, M., Ng, M. R., Nia, H. T., Grahovac, J., Kao, S., et al. (2023) · doi:10.1158/2159-8290.22531343
Self-citationIncio, J., Liu, H., Suboj, P., Chin, S. M., Chen, I. X., Pinter, M., Ng, M. R., Nia, H. T., Grahovac, J., Kao, S., et al. (2023) · doi:10.1158/2159-8290.22531343.v1
Self-citationNanotechnology and Precision Medicine
Alonazi, N. A., Albukhari, T. A., & Alruwaili, N. M. (2023) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9789815124606123010008
Xu, Q., Xue, S., Wang, Q., Zhang, Y., Li, J., Zhang, Y., & Li, F. (2023) · Research Square · doi:10.21203/rs.3.rs-3067874/v1
Yin, D., Sun, Q., Li, Y., Shen, W. H., Shang, W., Xu, Y., Yang, J., Chen, J., Gao, W., Wu, Q., et al. (2023) · Research Square · doi:10.21203/rs.3.rs-3259314/v1
Nanomechanical properties of soft particles
Cruz, R. G. D. L., & Zhang, Z. J. (2023) · Advances in chemical engineering · doi:10.1016/bs.ache.2023.10.001
Nanomedicine Based Therapies Against Cancer Stem Cells
Memişoğlu, A. S., & Tavşan, Z. (2023) · Recent advances in biotechnology · doi:10.2174/9789815179422123080011
Management of Primary Pancreatic Cancer
Pitiyarachchi, O., Kokkinos, J., Sharbeen, G., Phillips, P. A., Gandy, R. C., Haghighi, K. S., Moses, D. A., Thompson, S. R., Borbasi, J., Strutt, R., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch20
Porta, C., Negri, F., & Cosmai, L. (2024) · Cancer · doi:10.1002/cncr.35218
The Diverse Roles of the Tumour Microenvironment in Carcinogenesis
Al-Janabi, I. I. (2024) · Al-Rafidain Journal of Medical Sciences · doi:10.54133/ajms.v7i2.1464
Risk factor of severe diarrhea and enterocolitis induced by CAPOX: a retrospective multicenter study
Teixeira, A., Felismino, T. C., Donadio, M. D. S., Catani, G., Silva, A. L. M. D., Weschenfelder, R. F., Peixoto, R. D., O’Connor, J. M., Coutinho, A. K., & Riechelmann, R. P. (2024) · ESMO Gastrointestinal Oncology · doi:10.1016/j.esmogo.2024.100110
Bera, A. K., Ghosh, S., Ghosh, A. K., Ghosh, A., Vennam, S., Rizvi, M. S., & Pati, F. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.148449 · Cited by 1
Advanced strategies to improve the accumulation of nanotherapeutics in tumor
Choudhury, S., Tamang, R., Singh, V., Saad, M., Yadav, P., & Talegaonkar, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33343-9.00012-0 · Cited by 1
Majidi, A., Na, R., Jordan, S., Ross, T. L., Defazio, A., Friedlander, M., Grant, P., & Webb, P. (2025) · Cancer Epidemiology · doi:10.1016/j.canep.2025.102961
Metadata
- Authors
- Diop-Frimpong, B., Chauhan, V. P., Krane, S., Boucher, Y., & Jain, R. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Jain, Rakesh K.
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-01-31
- Volume
- 108
- Issue
- 7
- Pages
- 2909-2914
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3041115
- OpenAlex
- W2098054841
- Cited by
- 733
- References
- 54
- Citations by year
- 2026: 38 · 2025: 51 · 2024: 63 · 2023: 55 · 2022: 65 · 2021: 77 · 2020: 84 · 2019: 47 · 2018: 43 · 2017: 51 · 2016: 40 · 2015: 40 · 2014: 20 · 2013: 28 · 2012: 24
- FWCI
- 10.23
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Funders
- U.S. Department of Defense (W81XWH1010016, W81XWH)
- AstraZeneca
- FibroGen
- Astellas Pharma
- National Cancer Institute (W81XWH-10-1-0016, R01 CA 85140, R01CA98706, R01CA085140, P01CA080124, R01CA098706, P01-CA-80124)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular Mechanics and Interactions
- Keywords
- losartan, collagen I synthesis, desmoplasia, tumor stroma, nanotherapeutics, drug penetration, oncolytic herpes simplex virus, pegylated liposomal doxorubicin, cancer-associated fibroblasts, breast cancer, pancreatic cancer, skin cancer, antifibrotic agents, tumor microenvironment
- MeSH terms
- Analysis of Variance, Animals, Breast Neoplasms, Carcinoma, Collagen, Dose-Response Relationship, Drug, Doxorubicin, Female, Humans, Immunohistochemistry, Pancreatic Neoplasms, Polyethylene Glycols, Skin Neoplasms, Polymerase Chain Reaction, Drug Delivery Systems, Mice, SCID, DNA Primers, Simplexvirus, Losartan, Nanotechnology, Fluorescence Recovery After Photobleaching, Oncolytic Virotherapy, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review